Helen of Troy Limited (HELE) 10-Q 10 Oct 19 2020 Q2 Quarterly report Financial data

Cover page

Cover page - shares	6 Months Ended
	Aug. 31, 2019	Oct. 04, 2019
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2019
Document Transition Report	false
Entity File Number	001-14669
Entity Registrant Name	HELEN OF TROY LIMITED
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	74-2692550
Entity Address, Address Line One	1 Helen of Troy Plaza
Entity Address, State or Province	El Paso
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	79912
City Area Code	915
Local Phone Number	225-8000
Title of 12(b) Security	Common Shares, $0.10 Par Value Per Share
Trading Symbol	HELE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		25,163,993
Entity Central Index Key	0000916789
Current Fiscal Year End Date	--02-28
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false
Other Address
Entity Addresses [Line Items]
Entity Address, Address Line One	Clarendon House, 2 Church Street
Entity Address, State or Province	Hamilton
Entity Address, State or Province	BM

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
Assets, current:
Cash and cash equivalents	$ 17,031	$ 11,871
Receivables - principally trade, less allowances of $1,350 and $2,032	310,377	280,280
Inventory	370,915	302,339
Prepaid expenses and other current assets	13,048	10,369
Total assets, current	711,371	604,859
Property and equipment, net of accumulated depreciation of $130,059 and $123,744	131,164	130,338
Goodwill	602,320	602,320
Other intangible assets, net of accumulated amortization of $189,771 and $181,463	283,186	291,526
Operating lease assets	34,429
Deferred tax assets, net	12,398	7,991
Other assets, net of accumulated amortization of $2,161 and $2,115	1,085	12,501
Total assets	1,775,953	1,649,535
Liabilities, current:
Accounts payable, principally trade	166,684	143,560
Accrued expenses and other current liabilities	149,271	165,160
Income taxes payable	18	1,427
Long-term debt, current maturities	1,884	1,884
Total liabilities, current	317,857	312,031
Long-term debt, excluding current maturities	299,309	318,900
Lease liabilities, non-current	42,470
Deferred tax liabilities, net	8,323	5,748
Other liabilities, non-current	20,619	16,219
Total liabilities	688,578	652,898
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	0	0
Common stock, $0.10 par. Authorized 50,000,000 shares; 25,130,204 and 24,946,046 shares issued and outstanding	2,513	2,495
Additional paid in capital	256,995	246,585
Accumulated other comprehensive income (loss)	(4,755)	1,191
Retained earnings	832,622	746,366
Total stockholders' equity	1,087,375	996,637
Total liabilities and stockholders' equity	$ 1,775,953	$ 1,649,535

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
Statement of Financial Position [Abstract]
Receivables - principally trade, allowances (in dollars)	$ 1,350	$ 2,032
Property and equipment, accumulated depreciation (in dollars)	130,059	123,744
Other intangible assets, accumulated amortization (in dollars)	189,771	181,463
Other assets, accumulated amortization (in dollars)	$ 2,161	$ 2,115
Cumulative preferred stock, non-voting, par (in dollars per share)	$ 1	$ 1
Cumulative preferred stock, non-voting, authorized shares (in shares)	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares (in shares)	0	0
Common stock, par (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	25,130,204	24,946,046
Common stock, shares outstanding (in shares)	25,130,204	24,946,046

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Income Statement [Abstract]
Sales revenue, net	$ 413,995	$ 393,548	$ 790,330	$ 748,227
Cost of goods sold	235,844	238,375	458,452	446,496
Gross profit	178,151	155,173	331,878	301,731
Selling, general and administrative expense (SG&A)	123,201	103,654	229,102	205,160
Restructuring charges	430	859	1,049	2,584
Operating income	54,520	50,660	101,727	93,987
Non-operating income, net	89	85	221	160
Interest expense	(3,216)	(2,755)	(6,524)	(5,442)
Income before income tax	51,393	47,990	95,424	88,705
Income tax expense	5,298	3,973	8,635	6,515
Income from continuing operations	46,095	44,017	86,789	82,190
Loss from discontinued operations, net of tax	0	0	0	(381)
Net income	$ 46,095	$ 44,017	$ 86,789	$ 81,809
Earnings (loss) per share - basic:
Continuing operations (in dollars per share)	$ 1.84	$ 1.67	$ 3.46	$ 3.11
Discontinued operations (in dollars per share)	0	0	0	(0.01)
Total earnings per share - basic (in dollars per share)	1.84	1.67	3.46	3.09
Earnings (loss) per share - diluted:
Continuing operations (in dollars per share)	1.83	1.66	3.44	3.09
Discontinued operations (in dollars per share)	0	0	0	(0.01)
Total earnings per share - diluted (in dollars per share)	$ 1.83	$ 1.66	$ 3.44	$ 3.07
Weighted average shares of common stock used in computing earnings per share:
Basic (in shares)	25,116	26,359	25,068	26,467
Diluted (in shares)	25,245	26,557	25,245	26,612

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 46,095	$ 44,017	$ 86,789	$ 81,809
Other comprehensive income (loss), net of tax:
Cash flow hedge activity - interest rate swaps	(3,168)	101	(7,161)	205
Cash flow hedge activity - foreign currency contracts	424	478	1,215	3,811
Total other comprehensive income (loss), net of tax	(2,744)	579	(5,946)	4,016
Comprehensive income	$ 43,351	$ 44,596	$ 80,843	$ 85,825

Condensed Consolidated Statemen

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance (in shares) at Feb. 28, 2018		26,576,000
Beginning balance at Feb. 28, 2018	$ 1,014,459	$ 2,658	$ 230,676	$ 631	$ 780,494
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	82,190				82,190
Loss from discontinued operations	(381)				(381)
Other comprehensive income (loss), net of tax	4,016			4,016
Exercise of stock options (in shares)		111,000
Exercise of stock options	5,515	$ 11	5,504
Net issuance and settlement of restricted stock (in shares)		140,000
Net issuance and settlement of restricted stock	0	$ 14	(14)
Issuance of common stock related to stock purchase plan (in shares)		17,000
Issuance of common stock related to stock purchase plan	$ 1,335	$ 2	1,333
Common stock repurchased and retired (in shares)	(57,072,000)	(464,000)
Common stock repurchased and retired	$ (42,240)	$ (46)	(6,877)		(35,317)
Share-based compensation	11,013		11,013
Ending balance (in shares) at Aug. 31, 2018		26,380,000
Ending balance at Aug. 31, 2018	1,075,740	$ 2,635	241,633	4,647	826,825
Beginning balance (in shares) at May. 31, 2018		26,317,000
Beginning balance at May. 31, 2018	1,023,697	$ 2,629	233,783	4,068	783,217
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	44,017				44,017
Loss from discontinued operations	0
Other comprehensive income (loss), net of tax	579			579
Exercise of stock options (in shares)		67,000
Exercise of stock options	3,459	$ 7	3,452
Net issuance and settlement of restricted stock (in shares)		3,000
Net issuance and settlement of restricted stock	0
Issuance of common stock related to stock purchase plan	$ 0
Common stock repurchased and retired (in shares)	(7,477,000)	(7,000)
Common stock repurchased and retired	$ (692)		(292)		(400)
Share-based compensation	4,689		4,689
Ending balance (in shares) at Aug. 31, 2018		26,380,000
Ending balance at Aug. 31, 2018	1,075,740	$ 2,635	241,633	4,647	826,825
Beginning balance (in shares) at Feb. 28, 2019		24,946,000
Beginning balance at Feb. 28, 2019	996,637	$ 2,495	246,585	1,191	746,366
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	86,789				86,789
Other comprehensive income (loss), net of tax	$ (5,946)			(5,946)
Exercise of stock options (in shares)	61,765	62,000
Exercise of stock options	$ 3,633	$ 6	3,627
Net issuance and settlement of restricted stock (in shares)		178,000
Net issuance and settlement of restricted stock	0	$ 18	(18)
Issuance of common stock related to stock purchase plan (in shares)		15,000
Issuance of common stock related to stock purchase plan	$ 1,408	$ 1	1,407
Common stock repurchased and retired (in shares)	(70,558,000)	(71,000)
Common stock repurchased and retired	$ (9,131)	$ (7)	(8,591)		(533)
Share-based compensation	13,985		13,985
Ending balance (in shares) at Aug. 31, 2019		25,130,000
Ending balance at Aug. 31, 2019	1,087,375	$ 2,513	256,995	(4,755)	832,622
Beginning balance (in shares) at May. 31, 2019		25,101,000
Beginning balance at May. 31, 2019	1,036,179	$ 2,510	249,079	(2,011)	786,601
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Income from continuing operations	46,095				46,095
Other comprehensive income (loss), net of tax	$ (2,744)			(2,744)
Exercise of stock options (in shares)	26,368	27,000
Exercise of stock options	$ 1,807	$ 2	1,805
Net issuance and settlement of restricted stock (in shares)		5,000
Net issuance and settlement of restricted stock	0	$ 1	(1)
Issuance of common stock related to stock purchase plan (in shares)		0
Issuance of common stock related to stock purchase plan	$ 0	$ 0	0
Common stock repurchased and retired (in shares)	(2,354,000)	(3,000)
Common stock repurchased and retired	$ (343)		(269)		(74)
Share-based compensation	6,381		6,381
Ending balance (in shares) at Aug. 31, 2019		25,130,000
Ending balance at Aug. 31, 2019	$ 1,087,375	$ 2,513	$ 256,995	$ (4,755)	$ 832,622

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018
Cash provided by operating activities:
Net income	$ 86,789	$ 81,809
Less: Loss from discontinued operations	0	(381)
Income from continuing operations	86,789	82,190
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:
Depreciation and amortization	16,116	15,295
Amortization of financing costs	509	507
Non-cash operating lease asset amortization	1,022
Provision for doubtful receivables	313	597
Non-cash share-based compensation	13,985	11,013
(Gain) loss on the sale or disposal of property and equipment	(13)	49
Deferred income taxes and tax credits	4	5,650
Changes in operating capital, net of effects of acquisition of businesses:
Receivables	(30,410)	(38,647)
Inventories	(68,576)	(33,317)
Prepaid expenses and other current assets	(2,333)	(5,169)
Other assets and liabilities, net	22,284	(906)
Accounts payable	23,124	21,867
Accrued expenses and other current liabilities	(20,418)	(21,529)
Accrued income taxes	(4,185)	(289)
Net cash provided by operating activities - continuing operations	38,211	37,311
Net cash used by operating activities - discontinued operations	0	(381)
Net cash provided by operating activities	38,211	36,930
Cash used by investing activities:
Capital and intangible asset expenditures	(8,861)	(13,061)
Proceeds from the sale of property and equipment	0	0
Net cash used by investing activities - continuing operations	(8,861)	(13,061)
Net cash used by investing activities - discontinued operations	0	0
Net cash used by investing activities	(8,861)	(13,061)
Cash used by financing activities:
Proceeds from line of credit	283,400	292,300
Repayment of line of credit	(301,600)	(279,700)
Repayment of long-term debt	(1,900)	(1,900)
Proceeds from share issuances under share-based compensation plans	5,041	6,848
Payments for repurchases of common stock	(9,131)	(42,240)
Net cash used by financing activities - continuing operations	(24,190)	(24,692)
Net cash used by financing activities - discontinued operations	0	0
Net cash used by financing activities	(24,190)	(24,692)
Net decrease in cash and cash equivalents	5,160	(823)
Cash and cash equivalents, beginning balance	11,871	20,738
Cash and cash equivalents, ending balance	17,031	19,915
Less: Cash and cash equivalents of discontinued operations, ending balance	0	0
Cash and cash equivalents of continuing operations, ending balance	17,031	$ 19,915
Supplemental non-cash items not included above resulting from the adoption of ASC 842
Initial recognition of lease liabilities	$ 45,625

Basis of Presentation and Relat

Basis of Presentation and Related Information	6 Months Ended
	Aug. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Related Information	Basis of Presentation and Related Information The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2019 and February 28, 2019 , and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2019 , and our other reports on file with the Securities and Exchange Commission (“SEC”). When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. We refer to our common shares, par value $0.10 per share, as “common stock.” References to the "FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to United States (“U.S.”) generally accepted accounting principles. References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to "ASC" refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB. We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. We have three segments: Housewares, Health & Home, and Beauty. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation tools and storage containers; cleaning, bath and garden tools and accessories; infant and toddler care products; and insulated beverage, food containers and coolers. The Health & Home segment focuses on health care devices such as thermometers, humidifiers, blood pressure monitors, and heating pads; water filtration systems; and small home appliances such as portable heaters, fans, air purifiers, and insect control devices. Our Beauty segment products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid-, solid- and powder-based personal care and grooming products. On December 20, 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries to Direct Digital, LLC. The results of the Nutritional Supplements operations have been reported as discontinued operations for all periods presented in the consolidated financial statements. For more information, see Note 5 to these condensed consolidated financial statements. All other notes present results from continuing operations. Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30 th . We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany accounts and transactions are eliminated in consolidation. The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

New Accounting Pronouncements

New Accounting Pronouncements	6 Months Ended
	Aug. 31, 2019
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K for the fiscal year ended February 28, 2019. Adopted in Fiscal 2020 In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million , respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4). In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815)

Revenue Recognition

Revenue Recognition	6 Months Ended
	Aug. 31, 2019
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition We adopted the provisions of ASU 2014-9 in the first quarter of fiscal 2019, and we elected to adopt the standard using the retrospective method. The core principle of the guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Our revenue is primarily generated from the sale of non-customized consumer products to customers. Revenue is recognized when control of, and title to, the product sold transfers to the customer. Therefore, the timing and amount of revenue recognized was not materially impacted by the new guidance. We have thus concluded that the adoption of the guidance did not have a material impact on our consolidated financial statements. The provisions of the new guidance did however impact the classification of certain consideration paid to our customers. We therefore reclassified an immaterial amount of such payments from SG&A to a reduction of net sales revenue for all periods presented. Also, in accordance with the guidance, we reclassified an immaterial amount of estimated sales returns from a reduction of receivables to accrued expenses and other current liabilities for all periods presented. We elected to adopt the guidance using the full retrospective method. We measure revenue as the amount of consideration for which we expect to be entitled, in exchange for transferring goods. Certain customers may receive cash incentives such as customer discounts (including volume or trade discounts), advertising discounts and other customer-related programs which are accounted for as variable consideration. In some cases, we apply judgment, such as contractual rates and historical payment trends, when estimating variable consideration. In accordance with the guidance, most variable consideration is classified as a reduction to net sales.

Leases

Leases	6 Months Ended
	Aug. 31, 2019
Leases [Abstract]
Leases	Leases Adoption of the new lease standard resulted in the recording of lease assets and lease liabilities of approximately $37.1 million and $47.2 million , respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to unamortized lease incentives and deferred rent recorded in accordance with the previous lease guidance. The new standard did not materially impact our consolidated statements of income or cash flows. The Company primarily has leases for office space, which are classified as operating leases. Operating leases are included in operating lease assets, accrued expenses and other current liabilities, and lease liabilities, non-current in our consolidated balance sheets. Operating lease assets and operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As most of our lease contracts do not provide an explicit interest rate, we use an estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We include options to extend or terminate the lease in the lease term for accounting considerations, when it is reasonably certain that we will exercise that option. Our leases have remaining lease terms of 1 to 14 years. Lease expense for lease payments is recognized on a straight-line basis over the lease term in a manner similar to previous accounting guidance. We do not recognize leases with an initial term of twelve months or less on the balance sheet and instead recognize the related lease payments as expense in the condensed consolidated statements of income on a straight-line basis over the lease term. We account for lease and non-lease components as a single lease component for all asset classes. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Under the new guidance, operating lease expense recognized in the condensed consolidated statements of income during the three and six month periods ended August 31, 2019 was $1.7 million and $3.3 million , respectively. Short-term lease expense is excluded from this amount and is not material. The non-cash component of lease expense is included as an adjustment to reconcile income from continuing operations to net cash provided by operating activities in the condensed consolidated statements of cash flows. A summary of supplemental lease information is as follows: August 31, 2019 Weighted average remaining lease term (years) 11.1 Weighted average discount rate 6.09 % Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 2,112 A summary of our estimated lease payments, imputed interest and liabilities are as follows: (in thousands) Fiscal 2020 (balance for remainder of fiscal year) $ 2,470 Fiscal 2021 6,082 Fiscal 2022 5,959 Fiscal 2023 5,601 Fiscal 2024 5,102 Thereafter 40,132 Total future lease payments 65,346 Less: imputed interest (19,721 ) Present value of lease liability $ 45,625 August 31, 2019 Lease liabilities, current (1) $ 3,155 Lease liabilities, non-current 42,470 Total lease liability $ 45,625

Discontinued Operations

Discontinued Operations	6 Months Ended
	Aug. 31, 2019
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations In December 2017, we completed the divestiture of the Nutritional Supplements segment through the sale of Healthy Directions LLC and its subsidiaries ("Healthy Directions") to Direct Digital, LLC. The purchase price from the sale was comprised of $46.0 million in cash, which was paid at closing, and a supplemental payment with a target value of $25.0 million , payable on or before August 1, 2019. During fiscal 2019, the final amount of the supplemental payment was adjusted to $10.8 million based on a settlement with respect to the calculation of the performance of Healthy Directions through February 28, 2018. The adjustment resulted in a corresponding pre-tax charge of $5.8 million ( $4.4 million after tax) to discontinued operations. The supplemental payment of $10.8 million was received during the second quarter of fiscal 2020. Also, during fiscal 2019, we recorded additional net charges of $1.5 million ( $1.3 million

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	6 Months Ended
	Aug. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information PROPERTY AND EQUIPMENT (in thousands) Estimated Useful Lives (Years) August 31, 2019 February 28, 2019 Land - $ 12,644 $ 12,644 Building and improvements 3 - 40 113,619 113,820 Computer, software, furniture and other equipment 3 - 15 86,699 84,711 Tools, molds and other production equipment 3 - 7 37,000 36,378 Construction in progress - 11,261 6,529 Property and equipment, gross 261,223 254,082 Less accumulated depreciation (130,059 ) (123,744 ) Property and equipment, net $ 131,164 $ 130,338 ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (in thousands) August 31, 2019 February 28, 2019 Accrued compensation, benefits and payroll taxes $ 29,159 $ 36,782 Accrued sales discounts and allowances 28,924 28,655 Accrued sales returns 21,359 23,316 Accrued advertising 28,060 26,549 Other 41,769 49,858 Total accrued expenses and other current liabilities $ 149,271 $ 165,160

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Aug. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets We perform annual impairment tests each fiscal year during the fourth quarter and interim impairment tests, if and when necessary. For the three and six month periods ended August 31, 2019 and 2018, we did not record any impairment charges. The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented: August 31, 2019 February 28, 2019 (in thousands) Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Housewares: Goodwill $ 282,056 $ — $ — $ 282,056 $ 282,056 $ — $ — $ 282,056 Trademarks - indefinite 134,200 — — 134,200 134,200 — — 134,200 Other intangibles - finite 41,328 — (20,066 ) 21,262 41,417 — (19,398 ) 22,019 Subtotal 457,584 — (20,066 ) 437,518 457,673 — (19,398 ) 438,275 Health & Home: Goodwill 284,913 — — 284,913 284,913 — — 284,913 Trademarks - indefinite 54,000 — — 54,000 54,000 — — 54,000 Licenses - finite 17,050 — (15,577 ) 1,473 17,050 — (15,402 ) 1,648 Licenses - indefinite 7,400 — — 7,400 7,400 — — 7,400 Other intangibles - finite 118,024 — (93,373 ) 24,651 117,967 — (87,953 ) 30,014 Subtotal 481,387 — (108,950 ) 372,437 481,330 — (103,355 ) 377,975 Beauty: Goodwill 81,841 (46,490 ) — 35,351 81,841 (46,490 ) — 35,351 Trademarks - indefinite — — — — 30,407 — — 30,407 Trademarks - finite 30,557 — (1,956 ) 28,601 150 — (102 ) 48 Licenses - indefinite 10,300 — — 10,300 10,300 — — 10,300 Licenses - finite 13,696 — (12,641 ) 1,055 13,696 — (12,482 ) 1,214 Other intangibles - finite 46,402 — (46,158 ) 244 46,402 — (46,126 ) 276 Subtotal 182,796 (46,490 ) (60,755 ) 75,551 182,796 (46,490 ) (58,710 ) 77,596 Total $ 1,121,767 $ (46,490 ) $ (189,771 ) $ 885,506 $ 1,121,799 $ (46,490 ) $ (181,463 ) $ 893,846 After discontinuing the formal sale process and revising the strategic initiatives for our Personal Care business during the first quarter of fiscal year 2020, we changed trademarks related to the business with a net book value of $30.4 million from indefinite lived to finite lived assets. The amortization of these trademarks is now included in amortization expense for the six months ended August 31, 2019 , and these assets are expected to be fully amortized by the end of fiscal year 2027. The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025: Aggregate Amortization Expense For the three months ended (in thousands) August 31, 2019 $ 4,463 August 31, 2018 3,402 Aggregate Amortization Expense For the six months ended (in thousands) August 31, 2019 $ 8,339 August 31, 2018 7,522 Estimated Amortization Expense (in thousands) Fiscal 2020 $ 17,691 Fiscal 2021 16,135 Fiscal 2022 9,037 Fiscal 2023 8,847 Fiscal 2024 8,441 Fiscal 2025 6,977

Share-Based Compensation Plans

Share-Based Compensation Plans	6 Months Ended
	Aug. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation Plans	Share-Based Compensation Plans We have equity awards outstanding under several share-based compensation plans. During the three and six months ended August 31, 2019 , we had the following share-based compensation activity: • We issued 1,048 and 2,304 shares to non-employee Board members with a total grant date fair value of $0.1 and $0.2 million , respectively, and share prices of $134.21 and $121.99 , respectively. • We granted time-vested restricted stock units ("RSUs") that may be settled for 8 and 3,279 shares of common stock, respectively. The RSU grants have a weighted average grant price of $150.86 and $111.51 per share, respectively. For the three months ended August 31, 2019, the total award fair value was insignificant. For the six months ended August 31, 2019, the total award fair value at date of grant was $0.4 million. • We granted time-vested restricted stock awards ("RSAs") that may be vested for 4,920 and 45,772 shares of common stock, respectively. The RSA grants have a weighted average grant price of $138.86 and $113.98 per share, respectively, for a total award fair value at date of grant of $0.7 million and $5.2 million, respectively. • There were no grants of performance-based stock units ("PSUs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSUs that may be settled for 6,088 shares of common stock. The PSU grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $0.7 million. • There were no grants of performance-based restricted stock awards ("PSAs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSAs that are targeted to be vested for 122,402 shares of common stock. The PSA grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $13.6 million. • RSUs for 3,489 and 66,329 shares vested and settled, respectively, with a total fair value at settlement of $0.5 and $7.6 million and a weighted average share price of $146.26 and $114.58 , respectively. • There were no PSUs shares vested and settled during the three months ended August 31, 2019. For the six months ended August 31, 2019, there were 108,572 shares vested and settled with a total fair value at settlement of $14.7 million, and a weighted average share price of $135.85 . • RSAs for 928 shares vested and settled with a total fair value at settlement of $0.1 million and a weighted average share price of $150.86 during the three and six month periods ended August 31, 2019. • Employees exercised stock options to purchase 26,368 and 61,765 shares of common stock, respectively. • There were no purchases of common stock under the employee stock purchase plan during the three months ended August 31, 2019. For the six months ended August 31, 2019, employees purchased 14,790 shares of common stock under the employee stock purchase plan at an average price of $95.29 per share. We recorded the following share-based compensation expense in SG&A for the periods shown below: Three Months Ended August 31, (in thousands, except per share data) 2019 2018 Stock options $ 35 $ 219 Directors stock compensation 141 123 Performance based and other stock awards 6,205 4,347 Employee stock purchase plan — — Share-based compensation expense 6,381 4,689 Less income tax benefits (514 ) (341 ) Share-based compensation expense, net of income tax benefits $ 5,867 $ 4,348 Impact of share-based compensation on earnings per share from continuing operations: Basic $ 0.23 $ 0.16 Diluted $ 0.23 $ 0.16 Six Months Ended August 31, (in thousands, except per share data) 2019 2018 Stock options $ 151 $ 527 Directors stock compensation 281 246 Performance based and other stock awards 13,228 9,918 Employee stock purchase plan 325 322 Share-based compensation expense 13,985 11,013 Less income tax benefits (1,091 ) (611 ) Share-based compensation expense, net of income tax benefits $ 12,894 $ 10,402 Impact of share-based compensation on earnings per share from continuing operations: Basic $ 0.51 $ 0.39 Diluted $ 0.51 $ 0.39

Repurchases of Helen of Troy Co

Repurchases of Helen of Troy Common Stock	6 Months Ended
	Aug. 31, 2019
Equity [Abstract]
Repurchase of Helen of Troy Common Stock	Repurchase of Helen of Troy Common Stock On May 20, 2019, we announced that our Board of Directors had authorized the repurchase of up to $400 million of our outstanding common stock. The authorization is effective May 8, 2019 for a period of three years and replaced Helen of Troy's previous repurchase authorization, of which approximately $107.4 million remained. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. As of August 31, 2019 , our repurchase authorization allowed for the purchase of $394.0 million of common stock. Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the equity holder can be paid for by having the equity holder tender back to the Company a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown: Three Months Ended August 31, Six Months Ended August 31, (in thousands, except share and per share data) 2019 2018 2019 2018 Common stock repurchased on the open market: Number of shares — — — 407,025 Aggregate value of shares $ — $ — $ — $ 37,067 Average price per share $ — $ — $ — $ 91.07 Common stock received in connection with share-based compensation: Number of shares 2,354 7,477 70,558 57,072 Aggregate value of shares $ 344 $ 692 $ 9,131 $ 5,173 Average price per share $ 145.96 $ 92.55 $ 129.42 $ 90.65

Restructuring Plan

Restructuring Plan	6 Months Ended
	Aug. 31, 2019
Restructuring and Related Activities [Abstract]
Restructuring Plan	Restructuring Plan In October 2017, we announced that we had approved a restructuring plan (referred to as “Project Refuel”). Project Refuel includes a reduction-in-force and the elimination of certain contracts and operating expenses. We are targeting total annualized profit improvements of approximately $8.0 to $10.0 million over the duration of the plan. We estimate the plan will be completed during fiscal 2020, and expect to incur total restructuring charges of approximately $7.0 million over the duration of the plan. Restructuring provisions are determined based on estimates prepared at the time the restructuring actions are approved by management and are revised periodically. For the three and six month periods ended August 31, 2019 , we incurred $0.4 million and $1.0 million , respectively, of pre-tax restructuring charges related primarily to employee severance and termination benefits and lease termination costs. Since implementing Project Refuel, we have incurred $6.4 million of pre-tax restructuring costs related to employee severance and termination benefits and contract termination costs as of August 31, 2019 . During the three and six month periods ended August 31, 2019, we made total cash restructuring payments of $0.9 million and $1.5 million , respectively. Since implementing Project Refuel, we have made total cash restructuring payments of $5.8 million . We had a remaining liability of $0.7 million as of August 31, 2019 .

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Aug. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Matters – On May 31, 2018, we settled a patent infringement dispute related to two forehead thermometer models sold by our subsidiary, Kaz USA, Inc., in the United States and made a settlement payment of $15.0 million , which was accrued in prior periods along with related legal fees and other costs. We are involved in various other legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity. Lease Commitments – The implementation of the new lease guidance (ASC 842) using the effective date method requires the disclosure of our lease commitments from our latest annual report on Form 10-K for the interim periods during the first year of adoption (see Note 4). The lease commitments as of February 28, 2019 were as follows: Fiscal Years Ended the Last Day of February: 2020 2021 2022 2023 2024 After (in thousands) Total 1 year 2 years 3 years 4 years 5 years 5 years Operating leases $ 69,482 $ 5,171 $ 6,678 $ 6,411 $ 5,743 $ 5,078 $ 40,401 The minimum rental payments for operating leases presented above were determined in accordance with the previous lease guidance (ASC 840). Note 4 presents a summary of our estimated lease payments, imputed interest and liabilities as of August 31, 2019

Long-Term Debt

Long-Term Debt	6 Months Ended
	Aug. 31, 2019
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provided for an unsecured total revolving commitment of $1.0 billion as of August 31, 2019 . The commitment under the Credit Agreement terminates on December 7, 2021. Borrowings accrue interest under one of two alternative methods (based upon a base rate of LIBOR) as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment fees and letter of credit fees under the Credit Agreement. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. As of August 31, 2019 , the outstanding revolving loan principal balance was $283.0 million (excluding prepaid financing fees) and the face amount of outstanding letters of credit was $9.0 million . For the three and six month periods ended August 31, 2019 , borrowings under the Credit Agreement incurred interest charges at rates ranging from 3.1% to 5.5% . For the three and six month periods ended August 31, 2018 , borrowings under the Credit Agreement incurred interest charges at rates ranging from 2.9% to 5.0% and 2.8% to 5.0% , respectively. As of August 31, 2019 , the amount available for borrowings under the Credit Agreement was $708.0 million . Covenants in our debt agreements limit the amount of total indebtedness we can incur. As of August 31, 2019 , these covenants effectively limited our ability to incur more than $609.0 million of additional debt from all sources, including our Credit Agreement, or $708.0 million in the event a qualified acquisition is consummated. The following table summarizes our long-term debt as of the end of the periods shown: (in thousands) Original Date Borrowed Interest Rates Matures August 31, 2019 February 28, 2019 Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1) 03/13 Floating 03/23 $ 20,443 $ 22,335 Credit Agreement (2) 01/15 Floating 12/21 280,750 298,449 Total long-term debt 301,193 320,784 Less current maturities of long-term debt (1,884 ) (1,884 ) Long-term debt, excluding current maturities $ 299,309 $ 318,900 (1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0% , or a Base Rate plus a margin of up to 1.0% , as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018. The loan can be prepaid without penalty. The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement. Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps. At August 31, 2019 and February 28, 2019 , our long-term debt has floating interest rates, and its book value approximates its fair value. All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including a maximum leverage ratio and a minimum interest coverage ratio (as each of these terms is defined in the agreements). Our debt agreements also contain other customary covenants. We were in compliance with the terms of these agreements as of August 31, 2019 .

Fair Value

Fair Value	6 Months Ended
	Aug. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value	Fair Value We classify our various assets and liabilities recorded or reported at fair value under a hierarchy prescribed by GAAP that prioritizes inputs to fair value measurement techniques into three broad levels: Level 1: Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Assets and liabilities subject to classification are classified upon acquisition. When circumstances dictate the transfer of an asset or liability to a different level, our policy is to recognize the transfer at the beginning of the reporting period in which the event resulting in the transfer occurred. The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: Fair Values at August 31, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 1,232 Interest rate swaps — Foreign currency contracts 3,482 Total assets $ 4,714 Liabilities: Floating rate debt $ 301,193 Interest rate swaps 9,152 Foreign currency contracts — Total liabilities $ 310,345 Fair Values at February 28, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 915 Interest rate swaps 512 Foreign currency contracts 1,692 Total assets $ 3,119 Liabilities: Floating rate debt $ 320,784 Interest rate swaps 339 Foreign currency contracts 563 Total liabilities $ 321,686 (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The carrying amounts of cash and cash equivalents, receivables and accounts payable approximate fair value because of the short maturity of these items. We use derivatives for hedging purposes and our derivatives are primarily interest rate swaps, foreign currency contracts and cross-currency debt swaps. See Notes 12 and 14 to these condensed consolidated financial statements for more information on our hedging activities. We classify our floating rate debt as a Level 2 item because the estimation of the fair market value requires the use of a discount rate based upon current market rates of interest for obligations with comparable remaining terms. Such comparable rates are considered significant other observable market inputs. The book value of the floating rate debt approximates its fair value as of the reporting date. Our other non-financial assets include goodwill and other intangible assets, which we classify as Level 3 items. These assets are measured at fair value on a non-recurring basis as part of our impairment testing. Note 7 to these condensed consolidated financial statements contains additional information related to intangible asset impairments.

Financial Instruments and Risk

Financial Instruments and Risk Management	6 Months Ended
	Aug. 31, 2019
Financial Instruments, Owned, at Fair Value [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management Foreign Currency Risk - Our functional currency is the U.S. Dollar. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. During the three and six month periods ended August 31, 2019 , approximately 14% and 13% of our net sales revenue was in foreign currencies, respectively. During the three and six month periods ended August 31, 2018, approximately 11% and 13% of our net sales revenue was in foreign currencies, respectively. These sales were primarily denominated in Euros, British Pounds, Canadian Dollars, and Mexican Pesos. We make most of our inventory purchases from the Far East and primarily use the U.S. Dollar for such purchases. In our condensed consolidated statements of income, exchange gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign exchange gains and losses are recognized in SG&A. During the three and six month periods ended August 31, 2019, we recorded net foreign exchange gains from remeasurement, including the impact of currency hedges and the cross-currency debt swaps, of $0.8 million and $1.6 million , respectively, in SG&A. We recorded net foreign exchange gains from remeasurement, including the impact of foreign currency hedges and cross currency debt swaps of $0.5 million and losses of $1.2 million in SG&A during the three and six month periods ended August 31, 2018, respectively. We hedge against certain foreign currency exchange rate-risk by using a series of forward contracts and zero-cost collars designated as cash flow hedges and mark-to-market derivatives to protect against the foreign currency exchange risk inherent in our forecasted transactions denominated in currencies other than the U.S. Dollar. We do not enter into any forward exchange contracts or similar instruments for trading or other speculative purposes. The effective portion of the changes in fair value of these instruments is reported in OCI and reclassified into SG&A in the same period they are settled. The ineffective portion, which is not material for any year presented, is immediately recognized in SG&A. Interest Rate Risk - Interest on our outstanding debt as of August 31, 2019 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225.0 million of the outstanding principal balance under the Credit Agreement, which totaled $283.0 million (excluding prepaid finance fees) as of August 31, 2019 . The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: (in thousands) August 31, 2019 Derivatives designated as hedging instruments Hedge Type Final Settlement Date Notional Amount Prepaid Expenses and Other Current Assets Other Assets Accrued Expenses and Other Current Liabilities Other Liabilities, Non- current Zero-cost dollar - Euro Cash flow 02/2021 € 16,000 $ 207 $ 31 $ — $ — Foreign currency contracts - sell Euro Cash flow 12/2020 € 12,750 661 89 — — Foreign currency contracts - sell Canadian Dollars Cash flow 01/2021 $ 14,250 125 8 — — Zero-cost dollar - Pound Cash flow 02/2021 £ 10,250 237 49 — — Foreign currency contracts - sell Pound Cash flow 02/2021 £ 13,500 1,086 195 — — Foreign currency contracts - sell Mexican Pesos Cash flow 02/2020 $ 40,000 13 — — — Foreign currency contracts - Sell Australian Dollars Cash flow 10/2019 $ 2,000 46 — — — Interest rate swaps Cash flow 01/2024 $ 225,000 — — 2,513 6,639 Subtotal 2,375 372 2,513 6,639 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2020 € 5,280 431 — — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 304 — — — Subtotal 735 — — — Total fair value $ 3,110 $ 372 $ 2,513 $ 6,639 (in thousands) February 28, 2019 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost dollar - Euro Cash flow 02/2020 € 9,500 $ 11 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 01/2020 € 29,000 1,047 — — — Foreign currency contracts - sell Canadian Dollars Cash flow 02/2020 $ 16,000 168 — — — Zero-cost dollar - Pound Cash flow 05/2020 £ 4,500 — — 200 — Foreign currency contracts - sell Pound Cash flow 05/2020 £ 19,500 248 — — 13 Foreign currency contracts - sell Mexican Pesos Cash flow 09/2019 $ 30,000 — — 58 — Interest rate swaps Cash flow 01/2024 $ 225,000 512 — — 339 Subtotal 1,986 — 258 352 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2020 € 5,280 — 218 — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 — — — 292 Subtotal — 218 — 292 Total fair value $ 1,986 $ 218 $ 258 $ 644 (1) These are foreign currency contracts for which we have not elected hedge accounting. We refer to them as “cross-currency debt swaps”. They, in effect, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. The following table summarizes the pre-tax effect of derivative instruments for the periods shown: Three Months Ended August 31, Gain (Loss) Recognized in OCI (effective portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income Gain (Loss) Recognized As Income (in thousands) 2019 2018 Location 2019 2018 Location 2019 2018 Currency contracts - cash flow hedges $ (482 ) $ (51 ) SG&A $ (992 ) $ (610 ) $ — $ — Interest rate swaps - cash flow hedges (4,126 ) 137 Interest expense — — Interest expense 77 136 Cross-currency debt swaps - principal — — — — SG&A 344 243 Cross-currency debt swaps - interest — — — — Interest Expense — — Total $ (4,608 ) $ 86 $ (992 ) $ (610 ) $ 421 $ 379 Six Months Ended August 31, Gain (Loss) Recognized in OCI (effective portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income Gain (Loss) Recognized As Income (in thousands) 2019 2018 Location 2019 2018 Location 2019 2018 Currency contracts - cash flow hedges $ (668 ) $ 4,525 SG&A $ (2,210 ) $ 77 $ — $ — Interest rate swaps - cash flow hedges (9,326 ) 76 Interest expense — — Interest expense 231 211 Cross-currency debt swaps - principal — — — — SG&A 808 666 Cross-currency debt swaps - interest — — — — Interest expense 74 74 Total $ (9,994 ) $ 4,601 $ (2,210 ) $ 77 $ 1,113 $ 951 We expect pre-tax losses of $0.1 million associated with foreign currency contracts and interest rate swaps currently reported in accumulated other comprehensive income, to be reclassified into income over the next twelve months . The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. Counterparty Credit Risk - Financial instruments, including foreign currency contracts and cross currency debt swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. Although our theoretical credit risk is the replacement cost at the then-estimated fair value of these instruments, we believe that the risk of incurring credit losses is remote.

Segment Information

Segment Information	6 Months Ended
	Aug. 31, 2019
Segment Reporting [Abstract]
Segment Information	Segment Information The following tables present segment information included in continuing operations for the periods shown: Three Months Ended August 31, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 167,864 $ 158,790 $ 87,341 $ 413,995 Restructuring charges 2 — 428 430 Operating income 35,698 12,408 6,414 54,520 Capital and intangible asset expenditures 3,215 1,518 410 5,143 Depreciation and amortization 1,416 4,269 2,664 8,349 Three Months Ended August 31, 2018 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 137,498 $ 175,783 $ 80,267 $ 393,548 Restructuring charges — — 859 859 Operating income 28,329 13,631 8,700 50,660 Capital and intangible asset expenditures 5,642 2,466 771 8,879 Depreciation and amortization 1,522 4,229 1,562 7,313 Six Months Ended August 31, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 312,806 $ 313,733 $ 163,791 $ 790,330 Restructuring charges 90 — 959 1,049 Operating income 66,898 27,464 7,365 101,727 Capital and intangible asset expenditures 6,082 2,198 581 8,861 Depreciation and amortization 3,029 8,582 4,505 16,116 Six Months Ended August 31, 2018 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 254,801 $ 339,214 $ 154,212 $ 748,227 Restructuring charges 760 358 1,466 2,584 Operating income 50,512 33,288 10,187 93,987 Capital and intangible asset expenditures 7,296 4,655 1,110 13,061 Depreciation and amortization 3,006 8,377 3,912 15,295 We compute segment operating income based on net sales revenue, less cost of goods sold, SG&A, restructuring charges, and any asset impairment charges associated with the segment. The SG&A used to compute each segment’s operating income is directly associated with the segment, plus shared service and corporate overhead expenses that are allocable to the segment. We do not allocate non-operating income and expense, including interest or income taxes, to operating segments.

Income Taxes

Income Taxes	6 Months Ended
	Aug. 31, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items. For the three months ended August 31, 2019 , income tax expense as a percentage of income before income tax was 10.3% compared to 8.3% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates. For the six months ended August 31, 2019 , income tax expense as a percentage of income before income tax was 9.0% , which included $0.8 million of tax benefits from share-based compensation settlements, $1.7 million of expense from the remeasurement of deferred taxes due to tax rate changes, and a $2.8 million benefit from the resolution of an uncertain tax position. Income tax expense as a percentage of income before income tax was 7.3% for the same period last year, which included $0.5 million tax benefits from share-based compensation settlements and a $0.8 million benefit from the lapse of the statute of limitations related to an uncertain tax position. The year-over-year increase in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions and increases in certain statutory tax rates. During fiscal 2017, we received an assessment from a state tax authority which adjusted taxable income applicable to the particular state resulting from interpretations of certain state income tax provisions applicable to our legal structure. We believe we have accurately reported our taxable income and are vigorously protesting the assessment through administrative processes with the state. We believe it is unlikely that the outcome of these matters will have a material adverse effect on our consolidated financial position, results of operations, or liquidity. Our Macau subsidiary generates income from the sale of the goods that it has sourced and procured. This subsidiary is responsible for the sourcing and procurement of a large portion of the products that we sell. We currently have an indefinite tax holiday in Macau conditioned on the subsidiary meeting certain employment and investment thresholds. The Macau Offshore Law and its supplementary regulations that grant tax incentives to approved offshore institutions will be abolished on January 1, 2021. Existing approved offshore institutions such as ours can continue to operate under the offshore regime until the end of the calendar year 2020. Beginning in calendar year 2021, we believe our Macau subsidiary will become subject to a statutory corporate income tax of approximately 12%. The ultimate impact of this change, if any, on our overall effective tax rate will depend on a variety of factors including our mix of income by jurisdiction, transfer pricing considerations and the specific tax regulations applicable to us when we are no longer under the Macau Offshore regime. It is not practicable for us to determine the potential impact on our financial statements until the tax changes in Macau are fully established and our transfer pricing analysis is complete. Because our Macau subsidiary is not directly or indirectly owned by a U.S. parent, there is no U.S. tax liability associated with the income generated in Macau.

Earnings per Share

Earnings per Share	6 Months Ended
	Aug. 31, 2019
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested RSUs, PSUs, RSAs, PSAs and other stock based awards. See Note 8 to these condensed consolidated financial statements for more information regarding stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. The following table presents our weighted average basic and diluted shares for the periods shown: Three Months Ended Six Months Ended (in thousands) 2019 2018 2019 2018 Weighted average shares outstanding, basic 25,116 26,359 25,068 26,467 Incremental shares from share-based compensation arrangements 129 198 177 145 Weighted average shares outstanding, diluted 25,245 26,557 25,245 26,612 Antidilutive securities 166 194 259 352

Accumulated Other Comprehensive

Accumulated Other Comprehensive income (Loss)	6 Months Ended
	Aug. 31, 2019
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown: (in thousands) Interest Rate Swaps Foreign Currency Contracts Total Balance at February 28, 2018 $ 1,705 $ (1,074 ) $ 631 Other comprehensive income (loss) before reclassification 76 4,525 4,601 Amounts reclassified out of accumulated other comprehensive income — (77 ) (77 ) Tax effects 129 (637 ) (508 ) Other comprehensive income (loss) 205 3,811 4,016 Balance at August 31, 2018 $ 1,910 $ 2,737 $ 4,647 Balance at February 28, 2019 $ 132 $ 1,059 $ 1,191 Other comprehensive income (loss) before reclassification (9,326 ) (668 ) (9,994 ) Amounts reclassified out of accumulated other comprehensive income — 2,210 2,210 Tax effects 2,165 (327 ) 1,838 Other comprehensive income (loss) (7,161 ) 1,215 (5,946 ) Balance at August 31, 2019 $ (7,029 ) $ 2,274 $ (4,755 )

New Accounting Pronouncements (

New Accounting Pronouncements (Policies)	6 Months Ended
	Aug. 31, 2019
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements, Policy	Adopted in Fiscal 2020 In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) . The new guidance requires the recognition of lease liabilities, representing future minimum lease payments, on a discounted basis, and corresponding right-of-use assets on a balance sheet for most leases, along with requirements for enhanced disclosures to give financial statement users the ability to assess the amount, timing and uncertainty of cash flows arising from leasing arrangements. In July 2018, the FASB issued guidance which permits application of the new guidance at the beginning of the year of adoption, recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption, in addition to the method of applying the new guidance retrospectively to each prior reporting period presented. We adopted the standard in the first quarter of fiscal 2020 using the transition method introduced by ASU 2018-11, which does not require revisions to comparative periods. We elected to implement the transition package of practical expedients permitted within the new standard, which included (i) not reassessing whether expired or existing contracts contain leases, (ii) not reassessing lease classification, and (iii) not revaluing initial direct costs for existing leases. Adoption of the new standard resulted in the recording of initial lease assets and lease liabilities of approximately $37.1 million and $47.2 million , respectively, as of March 1, 2019. The difference between the lease assets and lease liabilities primarily relates to deferred rent and unamortized lease incentives recorded in accordance with the previous lease guidance. The new standard did not materially impact our condensed consolidated statements of income or cash flows (see Note 4). In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities (Topic 815) , which amends and simplifies hedge accounting with the intent of better aligning financial reporting for hedging relationships with an entity's risk management activities. In April 2019, the FASB issued ASU 2019-04, which provides clarifications and minor improvements related to Topic 815. Adoption of this guidance in the first quarter of fiscal 2020 did not have a material impact on our consolidated financial statements.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Aug. 31, 2019
Leases [Abstract]
Additional Lease Information	A summary of supplemental lease information is as follows: August 31, 2019 Weighted average remaining lease term (years) 11.1 Weighted average discount rate 6.09 % Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 2,112
Schedule of Operating Lease Maturities	A summary of our estimated lease payments, imputed interest and liabilities are as follows: (in thousands) Fiscal 2020 (balance for remainder of fiscal year) $ 2,470 Fiscal 2021 6,082 Fiscal 2022 5,959 Fiscal 2023 5,601 Fiscal 2024 5,102 Thereafter 40,132 Total future lease payments 65,346 Less: imputed interest (19,721 ) Present value of lease liability $ 45,625
Schedule of Lease Liabilities	August 31, 2019 Lease liabilities, current (1) $ 3,155 Lease liabilities, non-current 42,470 Total lease liability $ 45,625 (1) Included as part of "Accrued expenses and other current liabilities" on the condensed consolidated balance sheet.

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	6 Months Ended
	Aug. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Schedule of property and equipment	PROPERTY AND EQUIPMENT (in thousands) Estimated Useful Lives (Years) August 31, 2019 February 28, 2019 Land - $ 12,644 $ 12,644 Building and improvements 3 - 40 113,619 113,820 Computer, software, furniture and other equipment 3 - 15 86,699 84,711 Tools, molds and other production equipment 3 - 7 37,000 36,378 Construction in progress - 11,261 6,529 Property and equipment, gross 261,223 254,082 Less accumulated depreciation (130,059 ) (123,744 ) Property and equipment, net $ 131,164 $ 130,338
Schedule of accrued expenses and other current liabilities	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (in thousands) August 31, 2019 February 28, 2019 Accrued compensation, benefits and payroll taxes $ 29,159 $ 36,782 Accrued sales discounts and allowances 28,924 28,655 Accrued sales returns 21,359 23,316 Accrued advertising 28,060 26,549 Other 41,769 49,858 Total accrued expenses and other current liabilities $ 149,271 $ 165,160

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Aug. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of carrying amounts and associated accumulated amortization for all intangible assets by operating segment	The following table summarizes the carrying amounts and accumulated amortization for all intangible assets by segment as of the end of the periods presented: August 31, 2019 February 28, 2019 (in thousands) Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Gross Carrying Amount Cumulative Goodwill Impairments Accumulated Amortization Net Book Value Housewares: Goodwill $ 282,056 $ — $ — $ 282,056 $ 282,056 $ — $ — $ 282,056 Trademarks - indefinite 134,200 — — 134,200 134,200 — — 134,200 Other intangibles - finite 41,328 — (20,066 ) 21,262 41,417 — (19,398 ) 22,019 Subtotal 457,584 — (20,066 ) 437,518 457,673 — (19,398 ) 438,275 Health & Home: Goodwill 284,913 — — 284,913 284,913 — — 284,913 Trademarks - indefinite 54,000 — — 54,000 54,000 — — 54,000 Licenses - finite 17,050 — (15,577 ) 1,473 17,050 — (15,402 ) 1,648 Licenses - indefinite 7,400 — — 7,400 7,400 — — 7,400 Other intangibles - finite 118,024 — (93,373 ) 24,651 117,967 — (87,953 ) 30,014 Subtotal 481,387 — (108,950 ) 372,437 481,330 — (103,355 ) 377,975 Beauty: Goodwill 81,841 (46,490 ) — 35,351 81,841 (46,490 ) — 35,351 Trademarks - indefinite — — — — 30,407 — — 30,407 Trademarks - finite 30,557 — (1,956 ) 28,601 150 — (102 ) 48 Licenses - indefinite 10,300 — — 10,300 10,300 — — 10,300 Licenses - finite 13,696 — (12,641 ) 1,055 13,696 — (12,482 ) 1,214 Other intangibles - finite 46,402 — (46,158 ) 244 46,402 — (46,126 ) 276 Subtotal 182,796 (46,490 ) (60,755 ) 75,551 182,796 (46,490 ) (58,710 ) 77,596 Total $ 1,121,767 $ (46,490 ) $ (189,771 ) $ 885,506 $ 1,121,799 $ (46,490 ) $ (181,463 ) $ 893,846
Summary of amortization expense attributable to intangible assets	The following table summarizes the amortization expense attributable to intangible assets recorded in SG&A in the condensed consolidated statements of income for the periods shown below, as well as our estimated amortization expense for fiscal 2020 through 2025: Aggregate Amortization Expense For the three months ended (in thousands) August 31, 2019 $ 4,463 August 31, 2018 3,402 Aggregate Amortization Expense For the six months ended (in thousands) August 31, 2019 $ 8,339 August 31, 2018 7,522
Schedule of estimated amortization expense of intangible assets	Estimated Amortization Expense (in thousands) Fiscal 2020 $ 17,691 Fiscal 2021 16,135 Fiscal 2022 9,037 Fiscal 2023 8,847 Fiscal 2024 8,441 Fiscal 2025 6,977

Share-Based Compensation Plans

Share-Based Compensation Plans (Tables)	6 Months Ended
	Aug. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based compensation expense in SG&A	We recorded the following share-based compensation expense in SG&A for the periods shown below: Three Months Ended August 31, (in thousands, except per share data) 2019 2018 Stock options $ 35 $ 219 Directors stock compensation 141 123 Performance based and other stock awards 6,205 4,347 Employee stock purchase plan — — Share-based compensation expense 6,381 4,689 Less income tax benefits (514 ) (341 ) Share-based compensation expense, net of income tax benefits $ 5,867 $ 4,348 Impact of share-based compensation on earnings per share from continuing operations: Basic $ 0.23 $ 0.16 Diluted $ 0.23 $ 0.16 Six Months Ended August 31, (in thousands, except per share data) 2019 2018 Stock options $ 151 $ 527 Directors stock compensation 281 246 Performance based and other stock awards 13,228 9,918 Employee stock purchase plan 325 322 Share-based compensation expense 13,985 11,013 Less income tax benefits (1,091 ) (611 ) Share-based compensation expense, net of income tax benefits $ 12,894 $ 10,402 Impact of share-based compensation on earnings per share from continuing operations: Basic $ 0.51 $ 0.39 Diluted $ 0.51 $ 0.39

Repurchase of Helen of Troy Com

Repurchase of Helen of Troy Common Stock (Tables)	6 Months Ended
	Aug. 31, 2019
Equity [Abstract]
Summary of share repurchase activity	The following table summarizes our share repurchase activity for the periods shown: Three Months Ended August 31, Six Months Ended August 31, (in thousands, except share and per share data) 2019 2018 2019 2018 Common stock repurchased on the open market: Number of shares — — — 407,025 Aggregate value of shares $ — $ — $ — $ 37,067 Average price per share $ — $ — $ — $ 91.07 Common stock received in connection with share-based compensation: Number of shares 2,354 7,477 70,558 57,072 Aggregate value of shares $ 344 $ 692 $ 9,131 $ 5,173 Average price per share $ 145.96 $ 92.55 $ 129.42 $ 90.65

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	6 Months Ended
	Aug. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Other Commitments	The lease commitments as of February 28, 2019 were as follows: Fiscal Years Ended the Last Day of February: 2020 2021 2022 2023 2024 After (in thousands) Total 1 year 2 years 3 years 4 years 5 years 5 years Operating leases $ 69,482 $ 5,171 $ 6,678 $ 6,411 $ 5,743 $ 5,078 $ 40,401

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Aug. 31, 2019
Debt Disclosure [Abstract]
Summary of long-term debt	The following table summarizes our long-term debt as of the end of the periods shown: (in thousands) Original Date Borrowed Interest Rates Matures August 31, 2019 February 28, 2019 Mississippi Business Finance Corporation Loan (the "MBFC Loan") (1) 03/13 Floating 03/23 $ 20,443 $ 22,335 Credit Agreement (2) 01/15 Floating 12/21 280,750 298,449 Total long-term debt 301,193 320,784 Less current maturities of long-term debt (1,884 ) (1,884 ) Long-term debt, excluding current maturities $ 299,309 $ 318,900 (1) The MBFC Loan is unsecured with an original balance of $37.6 million and incurs floating interest based on applicable LIBOR plus a margin of up to 2.0% , or a Base Rate plus a margin of up to 1.0% , as determined by the interest rate elected and the Leverage Ratio. The loan is subject to holder’s call on or after March 1, 2018. The loan can be prepaid without penalty. The remaining principal balance is payable as follows: $1.9 million annually on March 1, 2020 through 2022; and $14.8 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. (2) Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $225 million of the outstanding principal balance under the Credit Agreement. Notes 13 and 14 to these condensed consolidated financial statements provide additional information regarding the interest rate swaps.

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Aug. 31, 2019
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy of financial assets and liabilities presented at fair value and measured on a recurring basis	The following tables present the fair value of our financial assets and liabilities measured on a recurring basis as of the end of the periods shown: Fair Values at August 31, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 1,232 Interest rate swaps — Foreign currency contracts 3,482 Total assets $ 4,714 Liabilities: Floating rate debt $ 301,193 Interest rate swaps 9,152 Foreign currency contracts — Total liabilities $ 310,345 Fair Values at February 28, 2019 (in thousands) (Level 2) (1) Assets: Money market accounts $ 915 Interest rate swaps 512 Foreign currency contracts 1,692 Total assets $ 3,119 Liabilities: Floating rate debt $ 320,784 Interest rate swaps 339 Foreign currency contracts 563 Total liabilities $ 321,686 (1) Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	6 Months Ended
	Aug. 31, 2019
Financial Instruments, Owned, at Fair Value [Abstract]
Schedule of fair values of derivative instruments	The following table summarizes the fair values of our derivative instruments as of the end of the periods shown: (in thousands) August 31, 2019 Derivatives designated as hedging instruments Hedge Type Final Settlement Date Notional Amount Prepaid Expenses and Other Current Assets Other Assets Accrued Expenses and Other Current Liabilities Other Liabilities, Non- current Zero-cost dollar - Euro Cash flow 02/2021 € 16,000 $ 207 $ 31 $ — $ — Foreign currency contracts - sell Euro Cash flow 12/2020 € 12,750 661 89 — — Foreign currency contracts - sell Canadian Dollars Cash flow 01/2021 $ 14,250 125 8 — — Zero-cost dollar - Pound Cash flow 02/2021 £ 10,250 237 49 — — Foreign currency contracts - sell Pound Cash flow 02/2021 £ 13,500 1,086 195 — — Foreign currency contracts - sell Mexican Pesos Cash flow 02/2020 $ 40,000 13 — — — Foreign currency contracts - Sell Australian Dollars Cash flow 10/2019 $ 2,000 46 — — — Interest rate swaps Cash flow 01/2024 $ 225,000 — — 2,513 6,639 Subtotal 2,375 372 2,513 6,639 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2020 € 5,280 431 — — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 304 — — — Subtotal 735 — — — Total fair value $ 3,110 $ 372 $ 2,513 $ 6,639 (in thousands) February 28, 2019 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Zero-cost dollar - Euro Cash flow 02/2020 € 9,500 $ 11 $ — $ — $ — Foreign currency contracts - sell Euro Cash flow 01/2020 € 29,000 1,047 — — — Foreign currency contracts - sell Canadian Dollars Cash flow 02/2020 $ 16,000 168 — — — Zero-cost dollar - Pound Cash flow 05/2020 £ 4,500 — — 200 — Foreign currency contracts - sell Pound Cash flow 05/2020 £ 19,500 248 — — 13 Foreign currency contracts - sell Mexican Pesos Cash flow 09/2019 $ 30,000 — — 58 — Interest rate swaps Cash flow 01/2024 $ 225,000 512 — — 339 Subtotal 1,986 — 258 352 Derivatives not designated under hedge accounting Foreign currency contracts - cross-currency debt swaps - Euro (1) 04/2020 € 5,280 — 218 — — Foreign currency contracts - cross-currency debt swaps - Pound (1) 04/2020 £ 6,395 — — — 292 Subtotal — 218 — 292 Total fair value $ 1,986 $ 218 $ 258 $ 644 (1)
Schedule of pre-tax effect of derivative instruments	The following table summarizes the pre-tax effect of derivative instruments for the periods shown: Three Months Ended August 31, Gain (Loss) Recognized in OCI (effective portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income Gain (Loss) Recognized As Income (in thousands) 2019 2018 Location 2019 2018 Location 2019 2018 Currency contracts - cash flow hedges $ (482 ) $ (51 ) SG&A $ (992 ) $ (610 ) $ — $ — Interest rate swaps - cash flow hedges (4,126 ) 137 Interest expense — — Interest expense 77 136 Cross-currency debt swaps - principal — — — — SG&A 344 243 Cross-currency debt swaps - interest — — — — Interest Expense — — Total $ (4,608 ) $ 86 $ (992 ) $ (610 ) $ 421 $ 379 Six Months Ended August 31, Gain (Loss) Recognized in OCI (effective portion) Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income Gain (Loss) Recognized As Income (in thousands) 2019 2018 Location 2019 2018 Location 2019 2018 Currency contracts - cash flow hedges $ (668 ) $ 4,525 SG&A $ (2,210 ) $ 77 $ — $ — Interest rate swaps - cash flow hedges (9,326 ) 76 Interest expense — — Interest expense 231 211 Cross-currency debt swaps - principal — — — — SG&A 808 666 Cross-currency debt swaps - interest — — — — Interest expense 74 74 Total $ (9,994 ) $ 4,601 $ (2,210 ) $ 77 $ 1,113 $ 951

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Aug. 31, 2019
Segment Reporting [Abstract]
Schedule of segment information	The following tables present segment information included in continuing operations for the periods shown: Three Months Ended August 31, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 167,864 $ 158,790 $ 87,341 $ 413,995 Restructuring charges 2 — 428 430 Operating income 35,698 12,408 6,414 54,520 Capital and intangible asset expenditures 3,215 1,518 410 5,143 Depreciation and amortization 1,416 4,269 2,664 8,349 Three Months Ended August 31, 2018 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 137,498 $ 175,783 $ 80,267 $ 393,548 Restructuring charges — — 859 859 Operating income 28,329 13,631 8,700 50,660 Capital and intangible asset expenditures 5,642 2,466 771 8,879 Depreciation and amortization 1,522 4,229 1,562 7,313 Six Months Ended August 31, 2019 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 312,806 $ 313,733 $ 163,791 $ 790,330 Restructuring charges 90 — 959 1,049 Operating income 66,898 27,464 7,365 101,727 Capital and intangible asset expenditures 6,082 2,198 581 8,861 Depreciation and amortization 3,029 8,582 4,505 16,116 Six Months Ended August 31, 2018 (in thousands) Housewares Health & Home Beauty Total Sales revenue, net $ 254,801 $ 339,214 $ 154,212 $ 748,227 Restructuring charges 760 358 1,466 2,584 Operating income 50,512 33,288 10,187 93,987 Capital and intangible asset expenditures 7,296 4,655 1,110 13,061 Depreciation and amortization 3,006 8,377 3,912 15,295

Earnings per Share (Tables)

Earnings per Share (Tables)	6 Months Ended
	Aug. 31, 2019
Earnings Per Share [Abstract]
Schedule of components of basic and diluted shares	The following table presents our weighted average basic and diluted shares for the periods shown: Three Months Ended Six Months Ended (in thousands) 2019 2018 2019 2018 Weighted average shares outstanding, basic 25,116 26,359 25,068 26,467 Incremental shares from share-based compensation arrangements 129 198 177 145 Weighted average shares outstanding, diluted 25,245 26,557 25,245 26,612 Antidilutive securities 166 194 259 352

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Aug. 31, 2019
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following table summarizes changes in accumulated other comprehensive income (loss) by component and related tax effects for periods shown: (in thousands) Interest Rate Swaps Foreign Currency Contracts Total Balance at February 28, 2018 $ 1,705 $ (1,074 ) $ 631 Other comprehensive income (loss) before reclassification 76 4,525 4,601 Amounts reclassified out of accumulated other comprehensive income — (77 ) (77 ) Tax effects 129 (637 ) (508 ) Other comprehensive income (loss) 205 3,811 4,016 Balance at August 31, 2018 $ 1,910 $ 2,737 $ 4,647 Balance at February 28, 2019 $ 132 $ 1,059 $ 1,191 Other comprehensive income (loss) before reclassification (9,326 ) (668 ) (9,994 ) Amounts reclassified out of accumulated other comprehensive income — 2,210 2,210 Tax effects 2,165 (327 ) 1,838 Other comprehensive income (loss) (7,161 ) 1,215 (5,946 ) Balance at August 31, 2019 $ (7,029 ) $ 2,274 $ (4,755 )

Basis of Presentation and Rel_2

Basis of Presentation and Related Information (Details)	6 Months Ended
	Aug. 31, 2019Segment$ / shares	Feb. 28, 2019$ / shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Common shares, par value (in dollars per share) | $ / shares	$ 0.10	$ 0.10
Number of segments | Segment	3

New Accounting Pronouncements -

New Accounting Pronouncements - Adopted (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Mar. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease assets	$ 34,429
Initial recognition of lease liabilities	$ (45,625)	$ (47,223)
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease assets		37,100
Initial recognition of lease liabilities		$ (47,200)

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Aug. 31, 2019	Aug. 31, 2019	Mar. 01, 2019
Lessee, Lease, Description [Line Items]
Operating lease assets	$ 34,429	$ 34,429
Present value of lease liability	45,625	45,625	$ 47,223
Operating lease expense	$ 1,700	$ 3,300
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease assets			37,100
Present value of lease liability			$ 47,200
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms		1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms		14 years

Leases - Additional Lease Infor

Leases - Additional Lease Information (Details) $ in Thousands	6 Months Ended
	Aug. 31, 2019USD ($)
Leases [Abstract]
Weighted average remaining lease term (years)	11 years 1 month 6 days
Weighted average discount rate	6.09%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 2,112

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Maturities (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Mar. 01, 2019
Leases [Abstract]
Fiscal 2020 (balance for remainder of fiscal year)	$ 2,470
Fiscal 2021	6,082
Fiscal 2022	5,959
Fiscal 2023	5,601
Fiscal 2024	5,102
Thereafter	40,132
Total future lease payments	65,346
Less: imputed interest	(19,721)
Present value of lease liability	$ 45,625	$ 47,223

Leases - Schedule of Lease Lia

Leases - Schedule of Lease Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Mar. 01, 2019
Leases [Abstract]
Lease liabilities, current	$ 3,155
Lease liabilities, non-current	42,470
Total lease liability	$ 45,625	$ 47,223

Discontinued Operation (Details

Discontinued Operation (Details) - Discontinued Operations - Healthy Directions LLC - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Aug. 31, 2019	Feb. 28, 2019	Feb. 28, 2018	Dec. 31, 2017
Discontinued Operations
Purchase price from sale				$ 46
Supplemental payment				$ 25
Final adjusted supplemental payment	$ 10.8		$ 10.8
Reduction of supplemental payment	5.8
Reduction of supplemental payment after tax	$ 4.4
Resolution of certain contingencies		$ 1.5
Resolution of certain contingencies after tax		$ 1.3

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2019	Feb. 28, 2019
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 261,223	$ 254,082
Less accumulated depreciation	(130,059)	(123,744)
Property and equipment, net	131,164	130,338
Land
PROPERTY AND EQUIPMENT
Property and equipment, gross	12,644	12,644
Building and improvements
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 113,619	113,820
Building and improvements | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Building and improvements | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	40 years
Computer, software, furniture and other equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 86,699	84,711
Computer, software, furniture and other equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Computer, software, furniture and other equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	15 years
Tools, molds and other production equipment
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 37,000	36,378
Tools, molds and other production equipment | Minimum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	3 years
Tools, molds and other production equipment | Maximum
PROPERTY AND EQUIPMENT
Estimated Useful Lives (Years)	7 years
Construction in progress
PROPERTY AND EQUIPMENT
Property and equipment, gross	$ 11,261	$ 6,529

Supplemental Balance Sheet In_4

Supplemental Balance Sheet Information - Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued compensation, benefits and payroll taxes	$ 29,159	$ 36,782
Accrued sales discounts and allowances	28,924	28,655
Accrued sales returns	21,359	23,316
Accrued advertising	28,060	26,549
Other	41,769	49,858
Total accrued expenses and other current liabilities	$ 149,271	$ 165,160

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of carrying amounts and associated accumulated amortization for all intangible assets by operating segment (Details) - USD ($) $ in Thousands	Aug. 31, 2019	May 31, 2019	Feb. 28, 2019
Changes in Goodwill
Cumulative goodwill impairments	$ (46,490)		$ (46,490)
Goodwill net book value	602,320		602,320
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(189,771)		(181,463)
Goodwill and intangible assets
Gross carrying amount	1,121,767		1,121,799
Net book value	885,506		893,846
Housewares
Changes in Goodwill
Goodwill gross carrying amount	282,056		282,056
Cumulative goodwill impairments	0		0
Goodwill net book value	282,056		282,056
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(20,066)		(19,398)
Goodwill and intangible assets
Gross carrying amount	457,584		457,673
Net book value	437,518		438,275
Housewares | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	41,328		41,417
Intangible assets - finite-lived, accumulated amortization	(20,066)		(19,398)
Intangible assets - finite-lived, net book value	21,262		22,019
Housewares | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	134,200		134,200
Health and Home
Changes in Goodwill
Goodwill gross carrying amount	284,913		284,913
Cumulative goodwill impairments	0		0
Goodwill net book value	284,913		284,913
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(108,950)		(103,355)
Goodwill and intangible assets
Gross carrying amount	481,387		481,330
Net book value	372,437		377,975
Health and Home | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	17,050		17,050
Intangible assets - finite-lived, accumulated amortization	(15,577)		(15,402)
Intangible assets - finite-lived, net book value	1,473		1,648
Health and Home | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	118,024		117,967
Intangible assets - finite-lived, accumulated amortization	(93,373)		(87,953)
Intangible assets - finite-lived, net book value	24,651		30,014
Health and Home | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	54,000		54,000
Health and Home | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	7,400		7,400
Beauty
Changes in Goodwill
Goodwill gross carrying amount	81,841		81,841
Cumulative goodwill impairments	(46,490)		(46,490)
Goodwill net book value	35,351		35,351
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, accumulated amortization	(60,755)		(58,710)
Goodwill and intangible assets
Gross carrying amount	182,796		182,796
Net book value	75,551		77,596
Beauty | Trademarks
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	30,557		150
Intangible assets - finite-lived, accumulated amortization	(1,956)		(102)
Intangible assets - finite-lived, net book value	28,601	$ 30,400	48
Beauty | Licenses
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	13,696		13,696
Intangible assets - finite-lived, accumulated amortization	(12,641)		(12,482)
Intangible assets - finite-lived, net book value	1,055		1,214
Beauty | Other intangible assets
Changes in intangible assets - finite-lived
Intangible assets - finite-lived, gross carrying amount	46,402		46,402
Intangible assets - finite-lived, accumulated amortization	(46,158)		(46,126)
Intangible assets - finite-lived, net book value	244		276
Beauty | Trademarks
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	0		30,407
Beauty | Licenses
Changes in intangible assets - indefinite-lived
Intangible assets - indefinite-lived, gross carrying amount	$ 10,300		$ 10,300

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Additional information (Details) - USD ($) $ in Thousands	Aug. 31, 2019	May 31, 2019	Feb. 28, 2019
Trademarks | Beauty
Finite-Lived Intangible Assets [Line Items]
Net book value transferred from indefinite lived to finite lived assets	$ 28,601	$ 30,400	$ 48

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Summary of amortization expense attributable to intangible assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Aggregate Amortization Expense	$ 4,463	$ 3,402	$ 8,339	$ 7,522

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of estimated amortization expense of intangible assets (Details) $ in Thousands	Aug. 31, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Fiscal 2020	$ 17,691
Fiscal 2021	16,135
Fiscal 2022	9,037
Fiscal 2023	8,847
Fiscal 2024	8,441
Fiscal 2025	$ 6,977

Share-Based Compensation Plan_2

Share-Based Compensation Plans (Details) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	Aug. 31, 2019USD ($)$ / sharesshares	Aug. 31, 2019USD ($)$ / sharesshares
Share-based compensation plans
Exercise of stock options (in shares)	26,368	61,765
Employee purchases of common stock (in shares)	0	14,790
Employee purchases of common stock, average price (in dollars per share) | $ / shares	$ 95.29	$ 95.29
Directors stock compensation
Share-based compensation plans
Number of awards granted (in shares)	1,048	2,304
Grant date fair value | $	$ 0.1	$ 0.2
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 134.21	$ 121.99
Restricted Stock Units (RSU)
Share-based compensation plans
Grant date fair value | $	$ 0.5	$ 7.6
Shares vested and settled (in shares)	3,489	66,329
Grant date fair value of shares settled in period (in dollars per share) | $ / shares	$ 146.26	$ 114.58
Shares vested (in shares)	3,489	66,329
Performance Restricted Stock Units (PSU)
Share-based compensation plans
Number of awards granted (in shares)	0	6,088
Grant date fair value | $		$ 0.7
Grant date fair value of shares granted in period (in dollars per share) | $ / shares		$ 110.85
Shares vested (in shares)	0	108,572
Performance Based Restricted Stock Awards (PSA)
Share-based compensation plans
Number of awards granted (in shares)	0	122,402
Grant date fair value | $		$ 13.6
Grant date fair value of shares settled in period (in dollars per share) | $ / shares		$ 110.85
Time-Vested | Restricted Stock Units (RSU)
Share-based compensation plans
Number of awards granted (in shares)	8	3,279
Grant date fair value | $		$ 0.4
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 150.86	$ 111.51
Time-Vested | Restricted Stock Awards (RSA)
Share-based compensation plans
Number of awards granted (in shares)	4,920	45,772
Grant date fair value | $	$ 0.7	$ 5.2
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 138.86	$ 113.98
Vested and settled performance shares | Restricted Stock Awards (RSA)
Share-based compensation plans
Grant date fair value | $	$ 0.1	$ 0.1
Grant date fair value of shares granted in period (in dollars per share) | $ / shares	$ 150.86	$ 150.86
Shares vested and settled (in shares)	928	928
Vested and settled performance shares | Performance Restricted Stock Units (PSU)
Share-based compensation plans
Grant date fair value | $		$ 14.7
Grant date fair value of shares granted in period (in dollars per share) | $ / shares		$ 135.85
Shares vested and settled (in shares)	0	108,572

Share-Based Compensation Plan_3

Share-Based Compensation Plans Share Based Compensation Expense in SG&A (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense, net of income tax benefits	$ 5,867	$ 4,348	$ 12,894	$ 10,402
Share Based Compensation Effect on Earnings Per Share [Abstract]
Basic (in dollars per share)	$ 0.23	$ 0.16	$ 0.51	$ 0.39
Diluted (in dollars per share)	$ 0.23	$ 0.16	$ 0.51	$ 0.39
SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 6,381	$ 4,689	$ 13,985	$ 11,013
Less income tax benefits	(514)	(341)	(1,091)	(611)
Stock options | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	35	219	151	527
Performance based and other stock awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	6,205	4,347	13,228	9,918
Employee stock purchase plan | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	0	0	325	322
Directors stock compensation | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 141	$ 123	$ 281	$ 246

Repurchase of Helen of Troy C_2

Repurchase of Helen of Troy Common Stock (Details) - USD ($)	May 08, 2019	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018	May 20, 2019
Repurchase of common stock
Amount of shares authorized for purchase						$ 400,000,000
Period for stock repurchase	3 years
Remaining share repurchase amount - prior program	$ 107,400,000
Remaining share repurchase amount		$ 394,000,000		$ 394,000,000
Repurchase of common stock
Number of shares (in shares)		2,354,000	7,477,000	70,558,000	57,072,000
Aggregate value of shares (in USD)		$ 343,000	$ 692,000	$ 9,131,000	$ 42,240,000
Average price per share (in dollars per share)		$ 145.96	$ 92.55	$ 129.42	$ 90.65
Open market or tender offer
Repurchase of common stock
Number of shares (in shares)		0	0	0	407,025,000
Aggregate value of shares (in USD)		$ 0	$ 0	$ 0	$ 37,067,000
Average price per share (in dollars per share)		$ 0	$ 0	$ 0	$ 91.07
Stock Compensation Plan
Repurchase of common stock
Aggregate value of shares (in USD)		$ 344,000	$ 692,000	$ 9,131,000	$ 5,173,000

Restructuring Plan (Details)

Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018	Feb. 29, 2020
Restructuring Plan
Restructuring charges	$ 430	$ 859	$ 1,049	$ 2,584
Cash restructuring payments for the reporting period	900		1,500
Project Refuel
Restructuring Plan
Restructuring charges	400		1,000
Incurred pre-tax restructuring costs	6,400		6,400
Cash restructuring payments to date			5,800
Restructuring liability	$ 700		700
Minimum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement			8,000
Maximum | Project Refuel
Restructuring Plan
Targeted annualized profit improvement			$ 10,000
Scenario, Forecast | Project Refuel
Restructuring Plan
Restructuring charges					$ 7,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	May 31, 2018USD ($)
Thermometer Patent Litigation | Settled Litigation
Commitments and contingencies
Settlement payment	$ 15

Commitments and Contingencies -

Commitments and Contingencies - Lease Commitments (Details) - Lease Agreements $ in Thousands	Aug. 31, 2019USD ($)
Other Commitments [Line Items]
Total	$ 69,482
2020	5,171
2021	6,678
2022	6,411
2023	5,743
2024	5,078
After 5 years	$ 40,401

Long-Term Debt - Schedule (Deta

Long-Term Debt - Schedule (Details)	3 Months Ended	6 Months Ended
	Aug. 31, 2018	Aug. 31, 2019USD ($)method	Aug. 31, 2018
Minimum | Credit agreement
Long-term debt
Interest rate range during each year (as a percent)	2.90%	3.10%	2.80%
Maximum | Credit agreement
Long-term debt
Interest rate range during each year (as a percent)	5.00%	5.50%	5.00%
MBFC loan
Long-term debt
Remaining principal balance due on March 1, 2023		$ 14,800,000
Credit agreement
Long-term debt
Maximum revolving commitment		$ 1,000,000,000
Number of alternative methods under which interest on borrowings accrue | method		2
Amount available for borrowings		$ 708,000,000
Maximum additional debt allowed under debt covenants		609,000,000
Revolving loan | Credit agreement
Long-term debt
Amount outstanding		283,000,000
Letter of credit | Credit agreement
Long-term debt
Amount outstanding		$ 9,000,000

Long-Term Debt - Summary of lon

Long-Term Debt - Summary of long-term debt (Details) - USD ($)	6 Months Ended
	Aug. 31, 2019	Feb. 28, 2019
Debt Instrument [Line Items]
Total long-term debt	$ 301,193,000	$ 320,784,000
Less current maturities of long-term debt	(1,884,000)	(1,884,000)
Long-term debt, excluding current maturities	299,309,000	318,900,000
MBFC loan
Debt Instrument [Line Items]
Total long-term debt	20,443,000	22,335,000
MBFC Loan original balance	37,600,000
Remaining principal balance due on March 1, 2020	1,900,000
Remaining principal balance due on March 1, 2021	1,900,000
Remaining principal balance due on March 1, 2022	1,900,000
Remaining principal balance due on March 1, 2023	$ 14,800,000
MBFC loan | LIBOR | Maximum
Debt Instrument [Line Items]
Interest rate	2.00%
MBFC loan | Base rate
Debt Instrument [Line Items]
Interest rate	1.00%
Credit agreement
Debt Instrument [Line Items]
Total long-term debt	$ 280,750,000	$ 298,449,000
Amount of interest rate swap hedge	$ 225,000,000

Fair Value (Details)

Fair Value (Details) - Recurring - Fair Values - Significant other observable market inputs (Level 2) - USD ($) $ in Thousands	Aug. 31, 2019	Feb. 28, 2019
Assets:
Total assets	$ 4,714	$ 3,119
Liabilities:
Total liabilities	310,345	321,686
Interest rate swap
Assets:
Derivative assets	0	512
Liabilities:
Derivative assets	9,152	339
Foreign currency contracts
Assets:
Derivative assets	3,482	1,692
Liabilities:
Derivative assets	0	563
Floating rate debt
Liabilities:
Floating rate debt	301,193	320,784
Money market accounts
Assets:
Money market accounts	$ 1,232	$ 915

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ 0.8	$ 0.5	$ 1.6	$ (1.2)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage	14.00%	11.00%	13.00%	13.00%

Financial Instruments and Ris_4

Financial Instruments and Risk Management - Interest Rate Risk (Details) - Credit agreement $ in Millions	Aug. 31, 2019USD ($)
Financial instruments and risk management
Fixed rate debt	$ 225
Floating rate debt	$ 283

Financial Instruments and Ris_5

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, $ in Thousands, $ in Thousands, $ in Thousands

Aug. 31, 2019USD ($)

Aug. 31, 2019CAD ($)

Aug. 31, 2019MXN ($)

Aug. 31, 2019EUR (€)

Aug. 31, 2019GBP (£)

Aug. 31, 2019AUD ($)

May 31, 2019USD ($)

Feb. 28, 2019USD ($)

Feb. 28, 2019CAD ($)

Feb. 28, 2019MXN ($)

Feb. 28, 2019EUR (€)

Feb. 28, 2019GBP (£)

Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

$ 3,110,000

$ 1,986,000

Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

372,000

218,000

Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

2,513,000

258,000

Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

6,639,000

644,000

Derivatives designated as hedging instruments | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

2,375,000

1,986,000

Derivatives designated as hedging instruments | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

372,000

0

Derivatives designated as hedging instruments | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

2,513,000

258,000

Derivatives designated as hedging instruments | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

6,639,000

352,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros

Fair values of derivative instruments in the consolidated balance sheet

Notional amount | €

€ 12,750

€ 29,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

661,000

1,047,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

89,000

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Euros | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars

Fair values of derivative instruments in the consolidated balance sheet

Notional amount

$ 14,250

$ 16,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

125,000

168,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

8,000

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Canadian Dollars | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds

Fair values of derivative instruments in the consolidated balance sheet

Notional amount | £

£ 13,500

£ 19,500

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

1,086,000

248,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

195,000

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Pounds | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

13,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos

Fair values of derivative instruments in the consolidated balance sheet

Notional amount

$ 40,000

$ 30,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

13,000

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

58,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Mexican Pesos | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars

Fair values of derivative instruments in the consolidated balance sheet

Notional amount

$ 2,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

46,000

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

Derivatives designated as hedging instruments | Foreign currency contracts | Sell | Australia, Dollars | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

$ 207,000

11,000

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

31,000

0

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Euros | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

$ 0

0

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds

Fair values of derivative instruments in the consolidated balance sheet

Notional amount

16,000

10,250

9,500

4,500

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

237,000

0

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

49,000

0

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

200,000

Derivatives designated as hedging instruments | Zero-Cost Collar Contract | Sell | Pounds | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives designated as hedging instruments | Interest rate swaps

Fair values of derivative instruments in the consolidated balance sheet

Notional amount

225,000,000

225,000,000

Derivatives designated as hedging instruments | Interest rate swaps | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

512,000

Derivatives designated as hedging instruments | Interest rate swaps | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

0

Derivatives designated as hedging instruments | Interest rate swaps | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

2,513,000

0

Derivatives designated as hedging instruments | Interest rate swaps | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

6,639,000

339,000

Derivatives not designated under hedge accounting | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

735,000

0

Derivatives not designated under hedge accounting | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

218,000

Derivatives not designated under hedge accounting | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives not designated under hedge accounting | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

292,000

Derivatives not designated under hedge accounting | Euros | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

218,000

Derivatives not designated under hedge accounting | Pounds | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros

Fair values of derivative instruments in the consolidated balance sheet

Notional amount | €

€ 5,280

€ 5,280

Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

431,000

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds

Fair values of derivative instruments in the consolidated balance sheet

Notional amount | £

£ 6,395

£ 6,395

Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid expenses and other current assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

304,000

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other assets

Fair values of derivative instruments in the consolidated balance sheet

Derivative assets

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued expenses and other current liabilities

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

0

0

Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other liabilities, non-current

Fair values of derivative instruments in the consolidated balance sheet

Derivative liabilities

$ 0

$ 292,000

Financial Instruments and Ris_6

Financial Instruments and Risk Management - Derivative tax effect (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	$ (4,608)		$ (9,994)
Gain (Loss) Recognized in OCI (effective portion)		$ 86		$ 4,601
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	(992)		(2,210)
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		(610)		77
Gain (Loss) Recognized As Income	421		1,113
Gain (Loss) Recognized As Income		379		951
Foreign currency contracts | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Recognized As Income	0		0
Gain (Loss) Recognized As Income		0		0
Foreign currency contracts | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	(482)		(668)
Gain (Loss) Recognized in OCI (effective portion)		(51)		4,525
Net loss currently reported in accumulated other comprehensive income, to be reclassified into income			$ 100
Net loss currently reported in accumulated other comprehensive income, to be reclassified into income, period of time to transfer			12 months
Foreign currency contracts | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	(992)		$ (2,210)
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		(610)		77
Interest rate swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Recognized As Income	77		231
Gain (Loss) Recognized As Income		136		211
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	(4,126)		(9,326)
Gain (Loss) Recognized in OCI (effective portion)		137		76
Interest rate swaps | Cash flow hedges | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		0		0
Cross currency debt swaps
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in OCI (effective portion)	0		0
Gain (Loss) Recognized in OCI (effective portion)		0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		0		0
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	0		0
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income		0		0
Gain (Loss) Recognized As Income	344		808
Gain (Loss) Recognized As Income		243		666
Cross currency debt swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Recognized As Income	$ 0		$ 74
Gain (Loss) Recognized As Income		$ 0		$ 74

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Segment information
Sales revenue, net	$ 413,995	$ 393,548	$ 790,330	$ 748,227
Restructuring charges	430	859	1,049	2,584
Operating income	54,520	50,660	101,727	93,987
Capital and intangible asset expenditures	5,143	8,879	8,861	13,061
Depreciation and amortization	8,349	7,313	16,116	15,295
Housewares
Segment information
Sales revenue, net	167,864	137,498	312,806	254,801
Restructuring charges	2	0	90	760
Operating income	35,698	28,329	66,898	50,512
Capital and intangible asset expenditures	3,215	5,642	6,082	7,296
Depreciation and amortization	1,416	1,522	3,029	3,006
Health and Home
Segment information
Sales revenue, net	158,790	175,783	313,733	339,214
Restructuring charges	0	0	0	358
Operating income	12,408	13,631	27,464	33,288
Capital and intangible asset expenditures	1,518	2,466	2,198	4,655
Depreciation and amortization	4,269	4,229	8,582	8,377
Beauty
Segment information
Sales revenue, net	87,341	80,267	163,791	154,212
Restructuring charges	428	859	959	1,466
Operating income	6,414	8,700	7,365	10,187
Capital and intangible asset expenditures	410	771	581	1,110
Depreciation and amortization	$ 2,664	$ 1,562	$ 4,505	$ 3,912

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Income Tax Disclosure [Abstract]
Income tax expense (benefit) as a percent of income before income taxes	10.30%	8.30%	9.00%	7.30%
Tax benefit recorded related to the recognition of excess tax benefits from share-based compensation			$ 0.8	$ 0.5
Expense for remeasurement of deferred taxes			1.7
Unrecognized tax benefit from favorable resolution of uncertain tax position			$ 2.8	$ 0.8

Earnings per Share (Details)

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
Weighted average diluted securities
Weighted average shares outstanding, basic (in shares)	25,116	26,359	25,068	26,467
Incremental shares from share-based payment arrangements (in shares)	129	198	177	145
Weighted average shares outstanding, diluted (in shares)	25,245	26,557	25,245	26,612
Stock options
Weighted average diluted securities
Antidilutive securities (in shares)	166	194	259	352

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2019	Aug. 31, 2018	Aug. 31, 2019	Aug. 31, 2018
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,036,179	$ 1,023,697	$ 996,637	$ 1,014,459
Total other comprehensive income (loss), net of tax	(2,744)	579	(5,946)	4,016
Ending balance	1,087,375	1,075,740	1,087,375	1,075,740
Interest Rate Swaps
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			132	1,705
Other comprehensive income (loss) before reclassification			(9,326)	76
Amounts reclassified out of accumulated other comprehensive income			0	0
Tax effects			2,165	129
Total other comprehensive income (loss), net of tax			(7,161)	205
Ending balance	(7,029)	1,910	(7,029)	1,910
Foreign Currency Contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			1,059	(1,074)
Other comprehensive income (loss) before reclassification			(668)	4,525
Amounts reclassified out of accumulated other comprehensive income			2,210	(77)
Tax effects			(327)	(637)
Total other comprehensive income (loss), net of tax			1,215	3,811
Ending balance	2,274	2,737	2,274	2,737
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(2,011)	4,068	1,191	631
Other comprehensive income (loss) before reclassification			(9,994)	4,601
Amounts reclassified out of accumulated other comprehensive income			2,210	(77)
Tax effects			1,838	(508)
Total other comprehensive income (loss), net of tax	(2,744)	579	(5,946)	4,016
Ending balance	$ (4,755)	$ 4,647	$ (4,755)	$ 4,647

Uncategorized Items - fy20q2hel

Label	Element	Value
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	$ 37,082,000
Non-Cash Increase (Decrease) In Other Accrued Liabilities	hele_NonCashIncreaseDecreaseInOtherAccruedLiabilities	(2,873,000)
Non-Cash Increase (Decrease) In Other Current Assets And Liabilities, Net	hele_NonCashIncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	(7,311,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(9,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(167,000)
Non-Cash Increase (Decrease) In Prepaid Expense And Other Assets	hele_NonCashIncreaseDecreaseInPrepaidExpenseAndOtherAssets	43,000
Additional Paid-in Capital [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(2,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	1,000
Retained Earnings [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(161,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(9,000)
Common Stock [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	(4,000)
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets	us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	$ (1,000)